Anna-Cajsa Ingridsson

Anna-Cajsa Ingridsson is a seasoned professional in clinical development and operations with extensive experience in leading clinical studies across various therapeutic areas. Currently serving as a Clinical Study Manager at Sobi since September 2023, Anna-Cajsa has previously held significant roles such as Head of Clinical Development at Synartro and Clinical Operations Director at Oncopeptides AB. In these positions, Anna-Cajsa demonstrated expertise in project management, operational strategy, and regulatory compliance, overseeing activities from study planning to close-out. Prior experience includes senior roles at Bayer and earlier positions supporting clinical trials at Kelly Scientific Resources and Karolinska Institutet. Anna-Cajsa holds a Master's degree in Molecular Biology from Umeå University and a Postgraduate Degree in Clinical and Industrial Drug Development from Uppsala University.